Frontiers | GLP-1 Receptor Agonists in Diabetic Kidney Disease: From Clinical Outcomes to Mechanisms | Pharmacology
Exenatide - Wikipedia
Clinical Focus on GLP-1 Agonists in Type 2 Diabetes Mellitus
Pharmacology of exenatide (synthetic exendin-4): a potential therapeutic for improved glycemic control of type 2 diabetes - ScienceDirect
Is Exenatide a Treatment for Parkinson's Disease? - IOS Press
A new mechanism of action of glucagon‐like peptide‐1 agonist in hepatic steatosis: Promotion of hepatic insulin clearance through induction of carcinoembryonic antigen‐related cell adhesion molecule 1 - Czech - 2018 - Hepatology
Exenatide – Beyond the Dish
Dipeptidyl peptidase-4 inhibitor Glucagon-like peptide-1 receptor agonist Liraglutide Dulaglutide, others, angle, text, pharmaceutical Drug png | PNGWing
Targeting GLP-1 receptor trafficking to improve agonist efficacy | Nature Communications
![exenatide [TUSOM | Pharmwiki]](https://tmedweb.tulane.edu/pharmwiki/lib/exe/fetch.php/glp1.png?w=600&tok=baf39c "exenatide [TUSOM | Pharmwiki]")
exenatide [TUSOM | Pharmwiki]
GLP-1 receptor agonists in type 2 diabetes: An underused asset? Updated January 2021 - DiabetesontheNet
A schematic representation of the mechanisms of increased macrophage... | Download Scientific Diagram
Exenatide, a GLP-1 receptor agonist, activates glucose transport in L6 muscle cell by an AMPK-dependent mechanism - Virtual Meeting | EASD
Hypothalamic Insulin-Sensitizing Effect of Exenatide in Dietary Induced Rat Model of Obesity | Bentham Science
Recent updates on GLP-1 agonists: Current advancements & challenges - ScienceDirect
![dpp-4_inhibitors [TUSOM | Pharmwiki]](https://tmedweb.tulane.edu/pharmwiki/lib/exe/fetch.php/dpp4.png?w=600&tok=f9724b "dpp-4_inhibitors [TUSOM | Pharmwiki]")
dpp-4_inhibitors [TUSOM | Pharmwiki]
Mechanism of the beneficial and protective effects of exenatide in diabetic rats in: Journal of Endocrinology Volume 220 Issue 3 (2014)
A new mechanism of action of glucagon‐like peptide‐1 agonist in hepatic steatosis: Promotion of hepatic insulin clearance through induction of carcinoembryonic antigen‐related cell adhesion molecule 1 - Czech - 2018 - Hepatology
Cardiovascular Actions and Clinical Outcomes With Glucagon-Like Peptide-1 Receptor Agonists and Dipeptidyl Peptidase-4 Inhibitors | Circulation
Targeting kinases in Parkinson's disease: A mechanism shared by LRRK2, neurotrophins, exenatide, urate, nilotinib and lithium - Journal of the Neurological Sciences
Mechanism of action of sitagliptin, vildagliptin, and exenatide. GLP-1... | Download Scientific Diagram
Differential Protective Effects of Exenatide, an Agonist of GLP-1 Receptor and Piragliatin, a Glucokinase Activator in Beta Cell Response to Streptozotocin-Induced and Endoplasmic Reticulum Stresses
